TNXB and ovarian serous adenocarcinoma: In this study we found that tenascin-X secretion by serous ovarian cancer cells purified from ascites taken during the follow-up of one patient had a strong positive correlation with circulating CA-125, suggesting that the secretion of CA-125 may correlate with the secretion of tenascin-X in the follow-up of patient.